Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma

Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma

Antidiabetic medication may modify the incidence of hepatocellular carcinoma (HCC). We aimed to compare the use of different antidiabetic strategies and the incidence of HCC. PubMed, Embase.com and Cochrane Library databases were searched up to 31 October 2015 and randomized controlled trials (RCTs)...

Full description

Bibliographic Details
Main Authors: Zhou, Yao-Yao, Zhu, Gui-Qi, Liu, Tian, Zheng, Ji-Na, Cheng, Zhang, Zou, Tian-Tian, Braddock, Martin, Fu, Shen-Wen, Zheng, Ming-Hua
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027387/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027387/

Similar Items